|
Sep 27
|
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Could Be Less Than A Year Away From Profitability
|
|
Sep 13
|
Aurinia to Participate in 2024 Cantor Fitzgerald Global Healthcare Conference
|
|
Sep 12
|
Aurinia Announces Board Restructuring
|
|
Aug 28
|
Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference
|
|
Aug 1
|
Aurinia Pharmaceuticals (AUPH) Q2 Earnings and Revenues Beat Estimates
|
|
Aug 1
|
Aurinia: Q2 Earnings Snapshot
|
|
Aug 1
|
Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational Results
|
|
Jun 14
|
Aurinia Announces 2024 Annual General Meeting Results
|
|
May 14
|
Analysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation’s Spring Clinical Meeting 2024
|
|
May 9
|
Aurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024
|
|
May 7
|
How Much Upside is Left in Aurinia (AUPH)? Wall Street Analysts Think 96.51%
|
|
May 7
|
Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference
|
|
May 3
|
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript
|
|
May 2
|
Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 2
|
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
|
|
May 1
|
Aurinia Underscores Enduring Commitment to People Living with Lupus Nephritis Through Innovative Advocacy and Education Initiatives for Lupus Awareness Month
|
|
Apr 30
|
The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program
|
|
Apr 16
|
UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference
|
|
Apr 15
|
Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024
|
|
Apr 9
|
Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference
|